Mylan Laboratories Limited Trastuzumab Export Data — India (DGFT 2022–2026)

Name: Mylan Laboratories Limited Trastuzumab Export Records India — #1 Exporter, 503 Shipments, $25.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Trastuzumab

India Pharmaceutical Trade Intelligence

$77.2M179 Suppliers108 CountriesHS 30049099

ExportsIndia → NETHERLANDS37.9%India → TURKEY13.1%

ImportsGERMANY → India$24.8B SWITZERLAND → India$448.1M

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN IRELAND

Mylan Laboratories Limited — Trastuzumab Exporter #1 | $25.1M Trade Value | TransData Nexus | TransData Nexus

Mylan Laboratories Limited — Trastuzumab Exporter Profile

Indian Pharmaceutical Exporter · #1 for Trastuzumab · $25.1M export value · DGFT Verified

Mylan Laboratories Limited is the #1 Indian exporter of Trastuzumab with $25.1M in export value and 503 verified shipments. Mylan Laboratories Limited holds a 32.6% market share in Trastuzumab exports across 7 countries. The company exports 91 pharmaceutical products worth $634.8M across 26 therapeutic categories.

Mylan Laboratories Limited — Trastuzumab Export Profile: Buyers & Destinations

Mylan Laboratories Limited Trastuzumab export treemap — buyers and destination countries | TransData Nexus

Where Does Mylan Laboratories Limited Export Trastuzumab?

Country	Value	Shipments	Share
NETHERLANDS	$9.1M	222	80.0%
TURKEY	$1.4M	28	12.1%
UKRAINE	$500.0K	10	4.4%
BRAZIL	$200.0K	4

Who Are the Top Buyers of Trastuzumab from Mylan Laboratories Limited?

Buyer	Country	Value	Orders
MYLAN IRELAND LIMITED	NETHERLANDS	$4.1M	108
MYLAN IRELAND LTD	NETHERLANDS	$2.7M	68
BIOSIMILAR COLLABORATIONS IRELAND L	NETHERLANDS	$2.1M	43
ABDI IBRAHIM ILAC SANAYI VE TICARET	TURKEY	$1.1M	22
PII OST-WEST EXPRESS	UKRAINE	$500.0K	10
ABDI IBRAHIM ILAC SANAYI VE TICARET SANAYIMAH TUNC	TURKEY	$272.0K	6
LIBBS FARMACEUTICA LTDA.	BRAZIL	$200.0K	4
BIOSIMILAR COLLABORATIONS	NETHERLANDS	$143.0K	3
MCDERMOTT LABORATORIES LTD	IRELAND	$89.5K	168
PHARMACIE CENTRAL DES HOPITAUX	ALGERIA	$50.0K	1

Mylan Laboratories Limited supplies Trastuzumab to 13 buyers globally. The largest buyer is MYLAN IRELAND LIMITED (NETHERLANDS), followed by MYLAN IRELAND LTD (NETHERLANDS) and BIOSIMILAR COLLABORATIONS IRELAND L (NETHERLANDS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Trastuzumab Formulations Does Mylan Laboratories Limited Export?

Product Description / Formulation	Value	Shipments
Trastuzumab lyophilized Powder for Injection (rDNA origin) 150 mg[Trastuzumab 150 mg powder for Concentrate for Solution	$500.0K	10
OGIVRI-150 TRASTUZUMAB 1S IRELAND (78022	$250.0K	5
OGIVRI-150-Trastuzumab- 1s-CYPRUS/GREECE	$200.0K	4
OGIVRI-420-Trastuzumab- 1s-POLAND - BATC	$150.0K	3
OGIVRI-420-Trastuzumab- 1s-GERMANY - BAT	$150.0K	3
OGIVRI-150-Trastuzumab- 1s-POLAND - BATC	$150.0K	3
OGIVRI-420-Trastuzumab- 1s-ITALY - BATCH	$150.0K	3
Trastuzumab lyophilized Powder for Injection rDNA origin 150 mg BATCH NO 3236585	$150.0K	3
OGIVRI-420-Trastuzumab- 1s GERMANY - BAT	$145.4K	3
OGIVRI-420-Trastuzumab- 1s-Italy - BATCH	$139.4K	3

Mylan Laboratories Limited exports 328 distinct Trastuzumab formulations including tablets, capsules, syrups, and combination drugs. The top formulation is Trastuzumab lyophilized Powder for Injection (rDNA origin) 1 with 10 shipments worth $500.0K.

How Does Mylan Laboratories Limited Compare to Nearest Trastuzumab Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	MYLAN LABORATORIES LIMITED ★	$25.1M	503	7	$50.0K
4	RELIANCE LIFE SCIENCES PRIVATE LIMITED	$3.8M	75	15	$50.0K
3	ZYDUS LIFESCIENCES LIMITED	$3.4M	68	8	$50.0K

Mylan Laboratories Limited ranks #1 among 179 Indian Trastuzumab exporters. Average shipment value of $50.0K compared to the market average of $208.0K. The closest competitors by value are RELIANCE LIFE SCIENCES PRIVATE LIMITED and ZYDUS LIFESCIENCES LIMITED.

Which Indian Ports Ship Trastuzumab Exports?

Port	Shipments	% Share
SAHAR AIR	379	20.1%
SAHAR AIR CARGO ACC (INBOM4)	319	17.0%
BANGALORE AIR	254	13.5%
BANGALORE ACC (INBLR4)	186	9.9%
Bombay Air	99	5.3%
DELHI AIR	74	3.9%
AHEMDABAD AIR ACC (INAMD4)	62	3.3%
Bangalore Air	58	3.1%

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Trastuzumab Exports

Mylan's export operations are influenced by a complex geopolitical landscape. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structure for Indian pharmaceutical exporters like Mylan. Additionally, diversions around the Cape of Good Hope have further elongated delivery schedules, posing challenges to time-sensitive pharmaceutical shipments.

In the United States, the imposition of tariffs on pharmaceutical imports has prompted Indian companies to reassess their market strategies. While generics have largely remained exempt, the potential for future tariff expansions necessitates vigilance. Mylan, along with other Indian exporters, is exploring market diversification to mitigate reliance on the U.S. market. The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a strategic avenue for expansion. The FTA eliminates tariffs on approximately 97% of EU tariff lines, including pharmaceuticals, thereby enhancing market access for Indian exporters. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, providing a counterbalance to uncertainties in the U.S. market.

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains paramount for Mylan. The FDA's warning letter and import alert in December 2024 concerning the Indore facility underscore the critical importance of stringent quality control measures. The cited violations, including subpar quality control and improper management of manufacturing defects, have necessitated comprehensive corrective actions. Mylan's proactive response aims to restore compliance and reinforce its commitment to quality assurance.

The evolving regulatory environment, particularly in the European Union, further emphasizes the need for adherence to Good Manufacturing Practices (GMP). The EU's Falsified Medicines Directive mandates rigorous compliance to ensure product integrity and patient safety. For Mylan, aligning with these standards is essential to maintain and expand its foothold in the European market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Trastuzumab shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Mylan Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 503 individual customs records matching Mylan Laboratories Limited exporting Trastuzumab, covering 328 formulations to 7 countries via 13 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 108+ countries, 329+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Trastuzumab

Trastuzumab

Mylan Laboratories Limited — Trastuzumab Exporter Profile

Mylan Laboratories Limited — Trastuzumab Export Profile: Buyers & Destinations

Where Does Mylan Laboratories Limited Export Trastuzumab?

Who Are the Top Buyers of Trastuzumab from Mylan Laboratories Limited?

What Is India's Total Trastuzumab Export Value and How Much Does Mylan Laboratories Limited Contribute?

What Is the Average Shipment Value for Mylan Laboratories Limited's Trastuzumab Exports?

How Does Mylan Laboratories Limited Compare to Other Indian Trastuzumab Exporters?

What Trastuzumab Formulations Does Mylan Laboratories Limited Export?

How Does Mylan Laboratories Limited Compare to Nearest Trastuzumab Exporters?

Which Indian Ports Ship Trastuzumab Exports?

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Trastuzumab Exports

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

About Mylan Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Trastuzumab Export Data from Mylan Laboratories Limited

Trastuzumab Stats

Company Overview

Top Products by Mylan Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source